OPRD1 and pneumonia: Wheatley and colleagues also showed that emerging oprD mutant clinical isolates of P. aeruginosa close to ST17, recovered over a 3-week period from patients suffering from pneumonia grew just as well as their ancestral strain and did not appear to be associated with a fitness costs in vitro [124].